APA (7th ed.) Citation

Vijayan Munusamy. (2017). Characteristics of epidermal growth factor receptor (EGFR)-mutated non small cell lung cancer (NSCLC) patients who developed resistance to first-or second-generation egfr-tyrosine kinase inhibitor (TKI) therapy through T790 mutation.

Chicago Style (17th ed.) Citation

Vijayan Munusamy. Characteristics of Epidermal Growth Factor Receptor (EGFR)-mutated Non Small Cell Lung Cancer (NSCLC) Patients Who Developed Resistance to First-or Second-generation Egfr-tyrosine Kinase Inhibitor (TKI) Therapy Through T790 Mutation. 2017.

MLA (8th ed.) Citation

Vijayan Munusamy. Characteristics of Epidermal Growth Factor Receptor (EGFR)-mutated Non Small Cell Lung Cancer (NSCLC) Patients Who Developed Resistance to First-or Second-generation Egfr-tyrosine Kinase Inhibitor (TKI) Therapy Through T790 Mutation. 2017.